Data on the association between hypothyroidism and glaucoma are conflicting. We sought to shed light on this by conducting a critical review and metaanalyses. The meta-analyses were conducted in adherence with the widely accepted MOOSE guidelines. Using the Medical Subject Heading (MeSH) terms: hypothyroidism, myxoedema and glaucoma or intraocular pressure, casecontrol studies, cohort studies and cross-sectional studies were identified (PubMed) and reviewed. Using meta-analysis, the relative risk (RR) of coexistence of glaucoma and hypothyroidism was calculated. Based on the literature search, thirteen studies fulfilled the inclusion criteria and could be categorized into two groups based on the exposure. The designs of the studies varied considerably, and there was heterogeneity related to lack of power, weak phenotype classifications and length of follow-up. Eight studies had glaucoma (5757 patients) as exposure and hypothyroidism as outcome. Among these, we found a non-significantly increased risk of hypothyroidism associated with glaucoma (RR 1.65; 95% confidence interval [CI]: 0.97-2.82). Based on five studies (168 006 patients) with hypothyroidism as exposure and glaucoma as outcome, we found the risk of glaucoma to be significantly increased (RR 1.33; 95% CI: 1.13-1.58). Based on these meta-analyses, there seems to be an association between hypothyroidism and glaucoma, which does not seem to be the case between glaucoma and hypothyroidism. However, larger scale studies with better phenotype classification, longer follow-up and taking comorbidity and other biases into consideration are needed to address a potential causal relationship.
Introduction
Hypothyroidism is a common condition with a prevalence of 1-2% (Carle et al. 2006; Vanderpump 2011) . The most common causes of hypothyroidism are autoimmune thyroiditis or the consequence of previous surgery or radioiodine treatment (Carle et al. 2006 ).
Irrespective of its cause, the standard treatment is levothyroxine (Garber et al. 2012) . Despite treatment, quality of life is affected, even long after euthyroidism has been restored (Watt et al. 2006; Winther et al. 2016) . In line with this, hypothyroidism has been associated with excess somatic (Thvilum et al. 2013a ) and psychiatric morbidity (Thvilum et al. 2014a ) as well as increased mortality (Thvilum et al. 2013b) . Hypothyroidism also increases the risk of early retirement and receiving disability pension compared to euthyroid controls (Nexo et al. 2014; Thvilum et al. 2014b ). Whether hypothyroidism is associated with increased intraocular pressure and thereby should be added to the list of morbidities is still debated.
Worldwide, glaucoma is one of the leading causes of vision impairment (Friedman et al. 2004) , and the pathology, a dysfunction of the trabecular meshwork, is acknowledged and well described (Sacca & Izzotti 2014) . More than 20 years ago, it was hypothesized that patients with hypothyroidism have an increased deposition of mucopolysaccharides in the trabecular meshwork, which initiates decreased aqueous outflow in addition to an increased intraocular pressure leading to glaucoma (Smith et al. 1992) . This hypothesis was supported by Smith et al. (1993) who found a significant increase in intraocular pressure in patients with hypothyroidism, indicating a link between hypothyroidism and glaucoma. However, the literature regarding a possible association between hypothyroidism and glaucoma is controversial, as is the direction of such a potential relationship. Whether this is due to too few and underpowered studies and/or various definitions of outcome and different study designs is unclarified (Karadimas et al. 2001) .
To evaluate a possible association, and its direction, between hypothyroidism and glaucoma, we performed a critical review and two meta-analyses.
Subjects and Methods
In addition to PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-analyses) (Moher et al. 2009 ), the meta-analyses were conducted in adherence with the recommendations of the MOOSE guidelines (Meta-analysis of Observational Studies in Epidemiology) including items such as background, search strategy, methods, results, discussion and conclusions (Stroup et al. 2000) .
Search method
On 1 July 2016, we performed a MED-LINE database search using the PubMed search engine with the Medical Subject Heading (MeSH) words hypothyroidism or myxoedema or thyroid disease and glaucoma or intraocular pressure. Only abstracts written in English were taken into account, but there were no restrictions with respect to gender, age, treatment modality, study design or study setting (hospital or primary health care). Abstracts were reviewed independently by two authors (MT and FB). In case of any disagreement between MT and FB, the abstract was also evaluated by the other authors and a conclusion was reached by a plenary discussion. Inclusion criteria were case-control, cohort or cross-sectional studies published in peerreviewed journals, which investigated whether hypothyroidism is associated with glaucoma or vice versa. Exclusion criteria were duplication of data or lack of a control group. Furthermore, to avoid missing any relevant study, the reference lists of studies included in this review were screened in search of overlooked publications. Characteristics of the participants, study design and confounders taken into account were retrieved from the included studies.
Analysis of studies
To evaluate homogeneity and identify bias, all included studies were compared with focus on selection of patients, reliability of diagnoses (self-reported, biochemical testing or register based), comparability of the control groups (age, gender and comorbidity) and major confounders (smoking and comorbidity). In case of an overlap of subjects in two or more studies, the largest study was used for further analyses. The quality of evidence of the studies was assessed independently by two authors (MT and FB).
Statistical analyses
Because of substantial qualitative and quantitative differences across studies, all analyses were performed using a random-effects model. This model assumes that the differences in observed effects among studies are not solely due to the sample size, but could also be due to other reasons, for example inclusion criteria of cases, age and sex distribution of study populations and differences in follow-up time. To compensate for the heterogeneity, the random-effects model not only weighs the studies based on size, but also based on the variance between the studies (Kirkwood & Stern 2003) . Statistically, the studies were analysed in two subgroups based on whether the exposure was hypothyroidism and the outcome glaucoma, or vice versa. The number of affected cases and controls were extracted from eligible studies. In case of lack of exact numbers, the percentages given were calculated into numbers. Consequently, the relative risk (RR) of glaucoma or hypothyroidism, with 95% confidence intervals (CI), was calculated by the method of DerSimonian & Laird (1986) . In case of no outcome either among cases or controls, the study was excluded from the analysis, for statistical reasons. Additionally, separate analyses were performed based on the design of the studies, this being follow-up or cross-sectional studies, respectively. Results were considered significant when the range of the 95% CI excluded the value 1. The statistical heterogeneity was assessed by the squared I-value, which describes the total variation across studies attributable to heterogeneity rather than to chance. A value between 25% and 49%, 50% and 74%, and 75% and 100% indicates low, moderate and high heterogeneity, respectively (Higgins et al. 2002) . We assessed publication bias by Egger's regression test (Davey Smith et al. 1997 ). Significant differences were defined as p-values < 0.05 using a two-tailed test. All analyses were carried out using version 13 of the STATA statistical package (StataCorp. 2013).
Results

Selection and characteristics of the studies
Study selection is detailed in the PRISMA flowchart in Fig. 1 ; 416 potential studies were identified. A total of 28 studies matched our additional criteria (Becker et al. 1966; Cheng & Perkins 1967; Pohjanpelto 1968; Henderson 1969; Sarda et al. 1972; Cartwright et al. 1992; Smith et al. 1993; Mezer et al. 1996; Boles Carenini et al. 1997; Centanni et al. 1997; Gillow et al. 1997; Gottfredsdottir et al. 1997; Munoz-Negrete et al. 2000; Tahat & Al-Khawaldeh 2000; Karadimas et al. 2001; Girkin et al. 2004; Lee et al. 2004; Cross et al. 2008; Motsko & Jones 2008; Ozturk et al. 2009; Hewitt et al. 2010; Kitsos et al. 2010; Lin et al. 2010a,b;  Calissendorff & Ljung 2011; Kim et al. 2012; Tripathy et al. 2014; Kakigi et al. 2015) . Following review, studies were excluded based on lack of a control population (Becker et al. 1966; Pohjanpelto 1968; Sarda et al. 1972; Boles Carenini et al. 1997; Gottfredsdottir et al. 1997; Tahat & Al-Khawaldeh 2000; Karadimas et al. 2001; Ozturk et al. 2009; Hewitt et al. 2010) , overlap with subjects from other studies (Lin et al. 2010b ), case reports (Mezer et al. 1996; Tripathy et al. 2014) , lack of eligibility for other reasons [no clinical trial (Henderson 1969) , no investigation of hypothyroidism (Becker et al. 1966)] or due to inability of retrieving the study (Centanni et al. 1997) . Thus, 13 studies were included for further analyses (Cartwright et al. 1992; Smith et al. 1993; Gillow et al. 1997; MunozNegrete et al. 2000; Girkin et al. 2004; Lee et al. 2004; Cross et al. 2008; Motsko & Jones 2008; Kitsos et al. 2010; Lin et al. 2010a; Calissendorff & Ljung 2011; Kim et al. 2012; Kakigi et al. 2015) . The included studies were published from 1992 until 2015, and details are shown in Table 1 . They were heterogeneous in terms of study size and design, and confounders considered. Thus, half of the studies were cross-sectional (Smith et al. 1993; Gillow et al. 1997; Lee et al. 2004; Cross et al. 2008; Kitsos et al. 2010; Kim et al. 2012; Kakigi et al. 2015) , whereas the majority of the remaining studies had a follow-up design (Cartwright, Girkin et al. 2004; Munoz-Negrete et al. 2000; Motsko & Jones 2008) . The most recent studies were cohort studies (Kim et al. 2012; Kakigi et al. 2015) and a register-based retrospective study (Calissendorff & Ljung 2011) . The majority of studies were from the USA (Cartwright et al. 1992; Girkin et al. 2004; Cross et al. 2008; Motsko & Jones 2008; Kakigi et al. 2015) or Europe (Gillow et al. 1997; MunozNegrete et al. 2000; Kitsos et al. 2010; Calissendorff & Ljung 2011) , while Taiwan (Lin et al. 2010a ), South Korea (Kim et al. 2012) , Canada (Smith et al. 1993) and Australia contributed one each. In general, the studies included few cases, only half of them more than 100 cases (Girkin et al. 2004; Lee et al. 2004; Cross et al. 2008; Motsko & Jones 2008; Lin et al. 2010a; Calissendorff & Ljung 2011; Kakigi et al. 2015) . By far, the largest study (Kakigi et al. 2015) and 4728 subjects (Motsko & Jones 2008) . The study of Kakigi et al. (2015) included to study groups, one larger including only self-reported hypothyroidism (n = 13 599) and a smaller including biochemical data on thyroid dysfunction (n = 3752). The studies were either conducted in a hospital setting (Smith et al. 1993; Munoz-Negrete et al. 2000; Kitsos et al. 2010) , in a local eye clinic (Cartwright et al. 1992; Gillow et al. 1997; Lee et al. 2004; Kim et al. 2012) or were register based (Motsko & Jones 2008; Lin et al. 2010a; Calissendorff & Ljung 2011; Kakigi et al. 2015) . The inclusion criteria for both cases and controls were also very heterogeneous.
Only five studies based the diagnosis of hypothyroidism on biochemical testing (Smith et al. 1993; Gillow et al. 1997; Munoz-Negrete et al. 2000; Kitsos et al. 2010; Kakigi et al. 2015) , while other studies based it on questionnaires (Smith et al. 1993; Munoz-Negrete et al. 2000; Lee et al. 2004; Cross et al. 2008; Kitsos et al. 2010; Kakigi et al. 2015) , treatment with thyroid hormone (Gillow et al. 1997; Girkin et al. 2004; Motsko & Jones 2008; Calissendorff & Ljung 2011) or medical records (Cartwright et al. 1992; Lin et al. 2010a ). Likewise, the definition of glaucoma was heterogeneous as it was based on clinical examination (Cartwright et al. 1992; Smith et al. 1993; MunozNegrete et al. 2000; Lee et al. 2004; Kitsos et al. 2010; Kim et al. 2012) , register-based data (Girkin et al. 2004; Motsko & Jones 2008; Lin et al. 2010a; Calissendorff & Ljung 2011) , selfreported questionnaires (Cross et al. 2008; Kakigi et al. 2015) or not given at all (Gillow et al. 1997) . Not only the diagnostic criteria for hypothyroidism and glaucoma varied between the studies, so did that for the controls. One study included controls with hypertensive glaucoma (Cartwright et al. 1992) , others included patients without the index disease from the same clinic (Smith et al. 1993 Kim et al. 2012 ). Of these, four studies found a significantly increased risk of hypothyroidism, based on the crude numbers given in the articles (Cartwright et al. 1992; Smith et al. 1993; Girkin et al. 2004; Kim et al. 2012 ). Of the remaining four studies, which failed to find a significant association between glaucoma and hypothyroidism (Gillow et al. 1997; Munoz-Negrete et al. 2000; Motsko & Jones 2008; Kitsos et al. 2010) , one study even found a non-significant tendency towards a protective effect on hypothyroidism (Munoz-Negrete et al. 2000) . The studies were pooled in a meta-analysis ( Fig. 2A) . Overall, there were 5757 glaucoma cases. In the study by Kitsos et al. (2010) , no individuals were found with clinical hypothyroidism, neither in the glaucoma group nor in the control group. Therefore, the study was excluded from the analysis. Based on the remaining seven studies, there was a non-significantly (RR 1.65, 95% CI: 0.97-2.82; p = 0.064) increased risk of hypothyroidism associated with glaucoma ( Fig. 2A) . As the squared I-value was 78.4%, the statistical heterogeneity was very pronounced. Importantly, no evidence of publication bias was detected (Egger's test, p = 0.451). Subdividing according to study design had a major effect on the risk estimates. When pooling studies with a cross-sectional design (Smith et al. 1993; Gillow et al. 1997; Kitsos et al. 2010; Kim et al. 2012 ), a diagnosis of glaucoma significantly increased the risk of hypothyroidism (RR = 3.20, 95% CI: 1.19-8.57, p = 0.021). In contrast, when evaluating the follow-up studies separately (Cartwright et al. 1992; Munoz-Negrete et al. 2000; Girkin et al. 2004; Motsko & Jones 2008) , the association between glaucoma and hypothyroidism attenuated and was no longer statistically significant (RR 1.18, 95% CI: 0.68-2.05; p = 0.556).
Glaucoma associated with hypothyroidism
Five studies, including six study populations, had hypothyroidism as exposure and glaucoma as outcome Cross et al. 2008; Lin et al. 2010a; Calissendorff & Ljung 2011; Kakigi et al. 2015) . Based on the crude numbers given in the articles, three found a significantly increased risk of glaucoma in subjects with hypothyroidism (Cross et al. 2008; Lin et al. 2010a; Calissendorff & Ljung 2011) , whereas one failed to find a significant association ). In the remaining study, including two study populations, results were conflicting as a significantly increased risk of glaucoma was found in one population but not in the other (Kakigi et al. 2015) . Overall, the studies included 168 006 hypothyroid individuals. When pooling the studies, we found a significantly increased risk of glaucoma associated with hypothyroidism, as shown in the forest plot in Fig. 2B (RR 1.33; 95% CI: 1.13-1.58; p = 0.001). The squared I-value indicated moderate heterogeneity (60.4%), while Egger's test gave no evidence of publication bias (p = 0.067).
Subdividing according to study design yielded essentially similar results in crosssectional studies Cross et al. 2008; Kakigi et al. 2015 ) (RR 1.40, 95% CI 1.21-1.62; p < 0.001), but was insignificant when pooling the two follow-up studies (Lin et al. 2010a ; Calissendorff & Ljung 2011) (RR 1.41, 95% CI 0.86-2.36; p = 0.13).
Discussion
The hypotheses of the studies considered in this paper fall into two categories. Does hypothyroidism lead to glaucoma and/or vice versa? Importantly, these two hypotheses cannot be evaluated in the same meta-analysis. On the one hand, our meta-analyses show a non-significantly increased risk of hypothyroidism in individuals with glaucoma, on the other hand, a statistically significantly increased risk of glaucoma in hypothyroid individuals. However, when interpreting the results, it is important to consider the multiple differences between the studies, and consider differences in study design, diagnostic criteria for hypothyroidism and glaucoma, definition of control groups, follow-up time and population size. Despite these differences, the results of the present meta-analysis are still valid and robust. Although the PRISMA guidelines have been strictly followed (Moher et al. 2009 ), meta-analyses of observational studies usually present particular challenges because of inherent biases and different study designs. Obviously, the result of a meta-analysis depends on the results of the included studies, which may be very heterogeneous. Had we applied the GRADE for evaluation of evidence level, which we could not as the included studies were not randomized controlled trials (RCT), the evidence level would have been low (Guyatt et al. 2010) . However, to improve and standardize the reporting, and thereby overcome some of these challenges, we took use of another verified checklist, MOOSE (Stroup et al. 2000) . Despite this, the present meta-analyses are to some degree hampered by heterogeneity of the studies.
Heterogeneity is especially distinct when considering the definition of hypothyroidism as well as glaucoma, and in most of the studies, the question of whether misclassifications may have biased the results remains unanswered. Studies have based the diagnosis of hypothyroidism on questionnaires (Smith et al. 1993; Munoz-Negrete et al. 2000; Cross et al. 2008; Kitsos et al. 2010; Kakigi et al. 2015) , registered treatment with levothyroxine (Gillow et al. 1997; Girkin et al. 2004; Motsko & Jones 2008; Calissendorff & Ljung 2011) or blood tests (Cartwright et al. 1992; Smith et al. 1993; Gillow et al. 1997; Kitsos et al. 2010; Kakigi et al. 2015) . As for the latter, the biochemical diagnostic criteria varied as well. Some of these definitions may, to an unknown degree, be impacted by, for example, recall bias thereby affecting comparability. Another pitfall is the lack of accounting for the hypothyroid phenotype. Depending on, for example, iodine intake level (Laurberg et al. 2010) , age of the individuals and genetic background (Brix et al. 2000a; Hansen et al. 2006) , hypothyroidism is most often caused by autoimmunity, previous surgery, radioiodine therapy or infections (Carle et al. 2006) . Clearly, the aetiology of hypothyroidism may impact the risk of glaucoma. In line with this, the inclusion (A) (B) Fig. 2 . The interrelation between hypothyroidism and glaucoma. The weight of each study in the overall analysis is represented by the size of the square boxes, and lines through boxes indicate confidence interval (CI). The diamond box indicates the overall relative risks (RR), the width of the diamond box indicates 95% CI and the dashed line through the centre shows the overall RR. and exclusion criteria for the controls varied considerably. Five studies selected the control population among individuals referred to an eye clinic, but without glaucoma (Cartwright et al. 1992; Smith et al. 1993; MunozNegrete et al. 2000; Girkin et al. 2004; Kitsos et al. 2010 ). This approach may skew the result, as individuals referred to a clinic are not representative of the background population, and therefore may have a higher degree of comorbidity. Unfortunately, only half of the studies ascertained the cases and controls from the general population Cross et al. 2008; Motsko & Jones 2008; Lin et al. 2010a; Calissendorff & Ljung 2011; Kim et al. 2012; Kakigi et al. 2015) . Finally, both hypothyroidism and glaucoma share risk factors, such as sex, age and environmental factors (Hansen et al. 2006; Doucette et al. 2015) . Four studies did not consider any confounders at all (Smith et al. 1993; Gillow et al. 1997; Munoz-Negrete et al. 2000; Kitsos et al. 2010) , while only two studies considered, for example, smoking (Lin et al. 2010a; Kim et al. 2012 ), known to have profound influence on risk of thyroid disease (Brix et al. 2000b ). Obviously, one cannot determine in what direction these shortcomings may have biased the results.
Six of the studies included fewer than 100 cases (Cartwright et al. 1992; Smith et al. 1993; Gillow et al. 1997; Munoz-Negrete et al. 2000; Girkin et al. 2004; Kitsos et al. 2010; Kim et al. 2012) . The fact that power calculations for cox regression analyses, estimated to identify a HR of 1.65, as found in our meta-analysis, would require a study population of 126 individuals indicates that half of the included studies were underpowered. In line with this, only two of the six studies with less than 126 cases were able to show a significant association between hypothyroidism and glaucoma (Smith et al. 1993; Kim et al. 2012) .
Independent of a potential association between hypothyroidism and glaucoma, the question of causality needs to be addressed. This is often performed by evaluating the following aspects of an association: strength, consistency, specificity, temporality, dose-response relation and biological plausibility (Hill 1965) . While one study pointed towards a 640% increased risk of hypothyroidism in individuals with glaucoma (Kim et al. 2012) , the results of our meta-analyses show a moderate risk of glaucoma in subjects with hypothyroidism (RR 1.33; 95% CI: 1.13-1.58) and an insignificantly increased risk of hypothyroidism in subjects with glaucoma (RR 1.65; 95% CI: 0.97-2.82). Looking at the RR, the latter may very well be due to the smaller number of individuals included and thereby a type 2 error. As for consistency, this was to some degree the case in studies with hypothyroidism as exposure, as three of four studies showed a positive association. On the other hand, we found no consistency in studies with glaucoma as exposure.
Based on the existing studies, it is not clear whether hypothyroidism might be the cause or the effect as six of the studies were cross-sectional, and it is impossible to draw conclusions on temporality from their findings (Smith et al. 1993; Gillow et al. 1997; Lee et al. 2004; Cross et al. 2008; Kitsos et al. 2010; Kim et al. 2012 ). Interestingly, when evaluating the follow-up studies separately, we did not find a significant risk of glaucoma among hypothyroid cases. However, only the study by Calissendorff & Ljung (2011) was designed in a way to allow evaluation of temporality. In that study, where the outcome (glaucoma) was defined as a first registration of antiglaucoma medication in the year following registration of thyroid medication and based on this, there was a positive association. This may indicate causality with hypothyroidism as exposure and glaucoma as outcome. However, in the original article, the result was nonsignificant, after adjustment for important confounders such as age, sex and marital status (Calissendorff & Ljung 2011) . With that in mind, in addition to the fact that our subanalyses were based on very few studies, the question of temporality remains unanswered.
As for biological plausibility (Hill 1965) , it has been suggested that increased deposition of mucopolysaccharides in the trabecular structures causes reversible increased ocular pressure due to decreased aqueous outflow (Smith et al. 1992; Boles Carenini et al. 1997) . Another explanation could be autoimmunity. While hypothyroidism is most often due to autoimmunity (Carle et al. 2006) , an autoimmune component may also be present in glaucoma (Grus et al. 2006) . As autoimmune diseases tend to coexist (Boelaert et al. 2010) , and at least thyroid autoimmunity is under genetic control (Brix & Hegedus 2012) , a possible shared predisposition could also be the biological explanation for an association between hypothyroidism and glaucoma. Interestingly, although the biological mechanisms may be the same for Graves' disease (Smith & Heged€ us 2016) , there has been little focus on a possible association between glaucoma and hyperthyroidism (Ohtsuka & Nakamura 2000).
An indicator of a possible causal relation between hypothyroidism and glaucoma would also be a dose-response relationship. Here, the studies point in diverging directions. No study has held duration and severity of hypothyroidism up against the risk of glaucoma. Few studies have differentiated between subclinical and overt hypothyroidism (Munoz-Negrete et al. 2000; Kitsos et al. 2010) . One study even found a nonsignificantly lower risk of subclinical hypothyroidism in individuals with glaucoma compared with the background population (Gillow et al. 1997 ). However, Lin et al. (2010a) found an increased risk of glaucoma only in untreated hypothyroid individuals, and not in individuals treated with levothyroxine. In support, Motsko & Jones (2008) reported a protective effect of treatment of hypothyroidism. In contrast, Karadimas et al. (2001) neither found an association between hypothyroidism and glaucoma, nor between TSH or free T3 levels and glaucoma.
The association between glaucoma and hypothyroidism, while biologically plausible, neither seems strong nor consistent, when evaluating the risk of hypothyroidism in individuals with glaucoma. In contrast, although based on few studies, there seems to be some consistency and the right temporality when evaluating the risk of glaucoma in hypothyroid individuals. What is needed to overcome the previously accounted for weaknesses? To detect supposedly relatively weak associations in the presence of a high prevalence of both hypothyroidism and glaucoma, well-powered case-control studies, with unambiguous definitions and known debut date of both hypothyroidism and glaucoma, a welldefined control group and a long follow-up time would be needed. Until such data are available, despite the present meta-analyses, the question of an increased risk of glaucoma in hypothyroid individuals and vice versa remains open.
